AxoGen, Inc.
General ticker "AXGN" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $988.9M (TTM average)
AxoGen, Inc. follows the US Stock Market performance with the rate: 53.3%.
Estimated limits based on current volatility of 2.3%: low 38.33$, high 40.17$
Factors to consider:
- Total employees count: 452 (+5.6%) as of 2024
- Top business risk factors: Operating inefficiencies and challenges, Leadership changes, Strategic risks and growth management, Geopolitical risks, Regulatory and compliance
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [21.01$, 38.81$]
- 2026-12-31 to 2027-12-31 estimated range: [18.86$, 35.60$]
Financial Metrics affecting the AXGN estimates:
- Positive: with PPE of 112.1 at the end of fiscal year the price was neutral
- Positive: -5.39 < Operating profit margin, % of -3.37
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: 42.59 < Shareholder equity ratio, % of 58.12 <= 64.29
- Negative: Operating cash flow per share per price, % of 0.05 <= 6.59
- Negative: 0.01 < Interest expense per share per price, % of 0.51
Short-term AXGN quotes
Long-term AXGN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $159.01MM | $187.34MM | $225.21MM |
| Operating Expenses | $180.47MM | $190.62MM | $233.06MM |
| Operating Income | $-21.46MM | $-3.29MM | $-7.85MM |
| Non-Operating Income | $-0.25MM | $-6.68MM | $-7.85MM |
| Interest Expense | $2.83MM | $8.21MM | $7.70MM |
| R&D Expense | $27.34MM | $27.77MM | $32.88MM |
| Income(Loss) | $-21.72MM | $-9.96MM | $-15.70MM |
| Net Income(Loss)* | $-21.72MM | $-9.96MM | $-15.70MM |
| Stockholders Equity | $95.67MM | $103.91MM | $128.85MM |
| Inventory | $23.02MM | $33.18MM | $42.37MM |
| Assets | $196.83MM | $203.73MM | $221.69MM |
| Operating Cash Flow | $-5.72MM | $4.54MM | $0.81MM |
| Capital expenditure | $14.92MM | $4.52MM | $3.75MM |
| Investing Cash Flow | $19.25MM | $-10.30MM | $-5.32MM |
| Financing Cash Flow | $1.95MM | $2.29MM | $10.50MM |
| Earnings Per Share** | $-0.51 | $-0.23 | $-0.34 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.